ホーム › 心房細動 › マサチューセッツ州 › Boston
Boston、MAにおける心房細動の臨床試験
Bostonとその周辺地域（約30マイル以内）の拠点で、心房細動に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
被験者募集中第3相
- Tufts Medical Center, Boston
- Mass General Hospital, Boston
- Brigham and Women's Hospital, Boston
- 他3件
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
被験者募集中第2相
- Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC), Boston
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
被験者募集中第4相
- Boston VA CSP Coordinating Center, Boston
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
被験者募集中観察研究
- Brigham and Women's Hospital, Boston
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
被験者募集中第2相
- Massachusetts General Hospital - Cardiology, Boston
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
被験者募集中
- Boston University Medical Center, Boston
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
被験者募集中
- Massachusetts General Hospital, Boston
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
被験者募集中
- Massachusetts General Hospital, Boston
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
被験者募集中第3相
- Anthos Investigative Site 9918, Boston
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
被験者募集中観察研究
- Brigham and Women's Hospital, Boston
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
被験者募集中第3相
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
被験者募集中早期第1相
- Brigham and Women Hospital, Boston
Medtronic Terminate AF Study
被験者募集中
- Massachusetts General Hospital, Boston
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
被験者募集中第3相
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
- 他1件
Positron Emission Tomography (PET) Imaging of Thrombosis
被験者募集中第1相健康なボランティア歓迎
- Massachusetts General Hospital, Boston
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
被験者募集中観察研究
- The Brigham and Womens Hospital, Boston
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
被験者募集中
- Brigham and Woman's Hospital, Boston
他の都市における心房細動の試験
- New York City, NY21件の研究
- Cleveland, OH17件の研究
- Atlanta, GA16件の研究
- Philadelphia, PA12件の研究
- Jonesboro, AR12件の研究
- Chicago, IL12件の研究
- Ann Arbor, MI11件の研究
- Pittsburgh, PA10件の研究
- Columbus, OH10件の研究
- Cincinnati, OH10件の研究
- Austin, TX9件の研究
- Los Angeles, CA9件の研究
Bostonにおける他の研究
- 乳がん111件の研究
- 非小細胞肺癌90件の研究
- がん（全種類）86件の研究
- 大腸癌63件の研究
- 転移性癌63件の研究
- 肺がん62件の研究
- 卵巣がん61件の研究
- 前立腺がん59件の研究
- うつ病52件の研究
- 子宮内膜がん50件の研究
- 心不全44件の研究
- 急性骨髄性白血病44件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。